NORVESTIA’S NET ASSET VALUE INCREASED BY 2.1% IN OCTOBER

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
NORVESTIA’S NET ASSET VALUE INCREASED BY 2.1% IN OCTOBER

Helsinki, Finland, 2015-11-11 09:00 CET (GLOBE NEWSWIRE) --  

Norvestia Oyj        Stock exchange release    11 November 2015 at 10:00

NORVESTIA’S NET ASSET VALUE INCREASED BY 2.1% IN OCTOBER  

Return on NAV, 1 month     2.1%  
Return on NAV, since beginning of year   7.3% (dividend-adjusted)
Return on Amended NAV, since beginning of year* 6.7% (dividend-adjusted)
Return on NAV, 12 months          7.5% (dividend-adjusted)
     
      31/10/2015 30/9/2015 31/12/2014
  Net Asset Value/share, EUR 9.99 9.78 9.59
  Amended Net Asset Value/share, EUR* 10.09 9.88 9.73
  Share price, EUR 7.80 7.32 7.40
           
  ASSETS EUR million EUR million EUR million
  NON-CURRENT ASSETS      
    Interests in associates 7.9 7.9 7.3
    Loan receivables from associates 1.7 1.7 1.9
    Other investments 6.5 6.4 4.6
    Deferred tax assets 3.9 3.5 3.7
           
  CURRENT ASSETS      
    Shares held for trading 69.7 62.2 65.4
    Other financial assets at fair      
    value 51.4 49.8 52.0
    Cash and receivables 20.6 26.1 17.1
  ASSETS IN TOTAL 161.7 157.6 152.0
           
  Current liabilities -2.3 -2.6 -0.4
  Deferred tax liabilities -6.4 -5.2 -4.7
           
  NET ASSET VALUE 153.0 149.8 146.9
  AMENDED NET ASSET VALUE* 154.6 151.4 149.0
               

Number of shares 15,316,560

* External valuations made to support the 2014 financial statements and confirm the fair values of growth equity investments resulted in an appreciation in the value of one of the associates, Coronaria Hoitoketju Oy. According to IFRS, this type of appreciation of investments in associates cannot be booked because the associates are accounted for in Norvestia's consolidated financial statements using the equity method.

ACCOUNTING PRINCIPLES

Shares held for trading mainly consist of listed shares and derivative contracts that are measured at fair value by the last trade price on active markets on the balance sheet date. Other financial assets at fair value consist mainly of funds whose fair value is determined as the funds’ Net Asset Value on the balance sheet date. The group also includes bonds, the fair value of which is measured at the last trade price on the balance sheet date.

Other investments include unlisted shares and private equity fund investments, which are measured at fair value. If the investments have no active market then the fair value is determined using various valuation methods that are usually based on forecasted cash flows. Private equity fund investments are valued according to the practice generally used in the sector, i.e. the fair value of the private equity fund investment is the latest fund value announced by the private equity fund management company.

Norvestia Oyj

Jonna Vaarnanen Financial Director Tel. +358-9-6226 380

DISTRIBUTION Nasdaq Helsinki Main media www.norvestia.fi

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Alaska's Insurance Maze: Coverage Over Cheap Policies

Updated Category News Views 92

Beyond Premiums: Assessing Real Coverage Needs The Alaskan wilderness isn't just home to stunning views; it's also a land where insurance needs to go beyond the average cookie-cutter policy. You'd think the cheapest option would suffice, but that's where residents might trip into financial quicksand. Devery Prince, a seasoned insurance principal, sheds light on why...

Continue Reading
Apalutamide Boosts Outlook for Prostate Cancer Treatment

Updated Category News Views 69

Fresh Findings on High-Risk Prostate Cancer Treatments In an industry that often feels like a game of chess, Johnson & Johnson's recent news unveils another one of their strategic moves with the announcement of breakthrough results from their Phase 3 PROTEUS substudy. Turns out, ERLEADA®, their apalutamide treatment, isn't just another pawn; it's a potential...

Continue Reading
Darden Faces Class Action Over Reimbursement Failures

Updated Category News Views 147

Class Action Puts Darden Restaurants in Legal Hot Seat Darden Restaurants, Inc. is staring down the barrel of a lawsuit that's as fiery as a grill on a Saturday night rush. The legal cavalry from Blumenthal Nordrehaug Bhowmik De Blouw LLP has stormed in with a class action complaint, aiming dead center at Darden for allegedly breaching the California Labor Code. In plain...

Continue Reading
ASTS Faces Crucial Deadline Amidst Legal Turmoil

Updated Category News Views 143

Ah, the ticking clock in the world of stock investments, where a nifty little thing called a class action lawsuit can flip your investment on its head. Right now, AST SpaceMobile (NASDAQ: ASTS) investors are staring down the barrel of one such lawsuit. With the November 13, 2026, deadline looming, it's time to sort the facts from the muck. Pins and Needles for ASTS...

Continue Reading
Lilly's Sofe-M Shakes Up Ovarian Cancer Treatment

Updated Category News Views 303

Ovarian Cancer Treatment Sees a New Challenger Alright, folks, Eli Lilly (NYSE:LLY) is stepping up with their latest findings in ovarian cancer treatment, and it's got plenty of people in a buzz. They've dropped new data for their investigational drug, Sofetabart mipitecan, or 'Sofe-M' for short, which targets this unrelenting disease with a punch that’s hard to ignore....

Continue Reading
CSTS Unveils PremierX in NYC: A Bold Entertainment Move

Updated Category News Views 185

Welcome to the New Era of Entertainment Out of the blockbusters and into the open air, eh? On October 30, 2026, CSTS Enterprises flipped the New York skyline into a canvas for their grand kickoff of PremierXTM—a live entertainment brand poised to redefine how we gobble up our music, sport, and art. Now, there's a shot of adrenaline New Yorkers weren't exactly begging...

Continue Reading
Amgen's IMDELLTRA® Shows Promise in SCLC Battle

Updated Category News Views 292

Breakthrough Results in SCLC Treatment For years, small cell lung cancer (SCLC) has been the unruly beast in the oncology world, defying treatment advances and keeping survival rates stubbornly low. This nasty foe might just have met its match, folks. Amgen (NASDAQ:AMGN) announced results from their Phase 3 DeLLphi-305 trial that show their drug IMDELLTRA®, when teamed...

Continue Reading
Likang's Bold Move: Cancer Immunotherapy at AD Summit

Updated Category News Views 96

Cancer Care Takes Center Stage Kicking off with a bang in Abu Dhabi, Likang Life Sciences has made a splash in the world of personalized cancer immunotherapy. The Abu Dhabi Future Health Summit 2026 served as the backdrop for this bold move, lighting up discussions with their AI-enabled innovations. Likang's showing at the Summit wasn't just another walk in the park—it...

Continue Reading
Taiwan Fuses Ancient TCM with Modern Bio Tech in 2026

Updated Category News Views 146

The Dynamic Fusion of Heritage and Innovation When you think about it, mixing centuries-old herbal wisdom with today's cutting-edge biotech might sound like a plot twist, but that's exactly what's cooking in Taiwan. Over at SupplySide Global 2026 in Las Vegas, Taiwan's got something more than just traditional medicine to flaunt; it's showcasing an impressive fusion of...

Continue Reading
Bio-Thera's New Data: A Game Changer for NSCLC?

Updated Category News Views 239

A Fresh Look at Lung Cancer Solutions There's fresh meat on the oncology block, with Bio-Thera Solutions swinging for the fences at ESMO 2026, spotlighting promising Phase 2 clinical data for their combo treatment in first-line non-small cell lung cancer (NSCLC). If you're tuned into the biopharmaceutical sector or just keeping tabs on global health romps, this news sets...

Continue Reading

Top 5 Most Recently Viewed Articles

Heights Wellness Retreat: A Bold Step Towards Holistic Wellness

Updated Category News Views 227

Heights Wellness Retreat: A New Era of Wellness In a landmark announcement during their annual summit, Massage Heights unveiled a significant transformation that redefines their brand identity. The brand, known for its commitment to wellness over the past two decades, will now operate under the name Heights Wellness Retreat. This evolution is more than just a new name; it...

Continue Reading
GeneDx Strengthens Leadership with New COO Appointment

Updated Category News Views 168

GeneDx Welcomes Bryan Dechairo as Chief Operating Officer GeneDx (NASDAQ: WGS) has made headlines with the appointment of Bryan Dechairo as its new Chief Operating Officer. This strategic decision aims to enhance operations and drive the company’s next phase of growth. Enhancing Operations for Future Success As COO, Dechairo will oversee critical areas including Product...

Continue Reading
FreightCar America to Share Q1 2025 Financial Results Soon

Updated Category News Views 130

FreightCar America Prepares for Q1 2025 Earnings Announcement FreightCar America, Inc. (NASDAQ: RAIL), a prominent player in the manufacturing of railroad freight cars, is gearing up to release its financial results for the first quarter of 2025. This important announcement is scheduled for after the market closes on a Monday, allowing investors and stakeholders to digest...

Continue Reading
Empowering Veterans: United Food Group's New Initiative

Updated Category News Views 129

United Food Group Unveils New Employment Initiative United Food Group, a noted developer and manufacturer of coffee equipment, powdered condiments, and beverages, has announced an innovative employment initiative designed to support wounded veterans and first responders. This program not only aims to empower these individuals but also provides them with specialized...

Continue Reading
US Futures Gain on Peace Talk Hopes Amid Market Developments

Updated Category News Views 206

U.S. Stock Futures Trend Upward U.S. stock futures saw an increase following the extended weekend, coming off a mixed trading day last Friday. The day off for Presidents Day allowed investors to reassess their positions. As a result, all four major indices posted gains in premarket trading. Investor Focus on Macro Conditions In today's trading, investors will closely...

Continue Reading